Copaxone

 
National Institutes of Health

Related topics

Related topics

3 relations
1 ML glatiramer acetate 40 MG/ML Prefilled Syringe [Copaxone]

Broader (2)

Glatiramerglatiramer acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice
EAE is a common animal model for multiple sclerosis (MS). Immunomodulatory treatments such as glatiramer acetate (GA, Copaxone… (More)
Is this relevant?
2008
2008
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
PURPOSE Drusen formation in age-related macular degeneration (AMD) shares some similarities with Alzheimer's disease (AD), which… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.
Glatiramer acetate (GA; copolymer-1, Copaxone) suppresses the induction of experimental autoimmune encephalomyelitis and reduces… (More)
Is this relevant?
2003
2003
Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.
CD4(+)CD25(high) T regulatory (Tr) cells, representing high IL-2 receptor alpha chain expressing cells, have been shown to… (More)
Is this relevant?
2001
2001
Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone®
Humoral and cellular immune responses were followed in multiple sclerosis patients treated with Copolymer 1 (Cop1, glatiramer… (More)
Is this relevant?
2001
2001
Predictors of adherence to Copaxone therapy in individuals with relapsing-remitting multiple sclerosis.
The purpose of this study was to evaluate psychological, biophysical, and sociodemographic variables as predictors of adherence… (More)
Is this relevant?
2001
2001
Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells.
Copolymer-1 (Copaxone or COP) inhibits experimental allergic encephalomyelitis and has beneficial effects in multiple sclerosis… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
We examined the effect of glatiramer acetate, a random copolymer of alanine, lysine, glutamic acid, and tyrosine, on antigen… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Treatment of multiple sclerosis with Copolymer-1 (Copaxone®): implicating mechanisms of Th1 to Th2/Th3 immune-deviation
The synthetic polypeptide copolymer-1 (Cop-1; Copaxone; Glatiramer Acetate) has been recently approved as an effective treatment… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study…
When 251 relapsing-remitting patients with multiple sclerosis were randomized to receive daily subcutaneous injections of… (More)
Is this relevant?